Conversion to positive latent tuberculosis infection status is low in patients with hidradenitis suppurativa taking biologic medications - 19/06/20
Doi : 10.1016/j.jaad.2020.01.012
Ariana Ellis, BS a, b, Urmi Khanna, MD b, AbdulAziz Galadari, MD b, Anthony P. Fernandez, MD, PhD b, c, ⁎ 
a Northeast Ohio Medical University, Rootstown, Ohio
b Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
c Department of Pathology, Cleveland Clinic, Cleveland, Ohio
∗Correspondence to: Anthony P. Fernandez, MD, PhD, Cleveland Clinic, 9500 Euclid Ave, A61, Cleveland, OH 44195Cleveland Clinic9500 Euclid Ave, A61ClevelandOH44195
| Funding sources: None. |
|
| Conflicts of interest: Dr Fernandez receives research support from Mallinckrodt, Corbus, Pfizer, and Novartis, and honorarium from AbbVie, Novartis, UCB, and Mallinckrodt for consulting, advisory board participation, and speaking. Ariana Ellis and Drs Khanna and Galadari have no conflicts of interest to declare. |
|
| IRB approval status: The Cleveland Clinic Institutional Review Board approved the study. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 83 - N° 1
P. 246-248 - luglio 2020 Ritorno al numero
Articolo precedente
- Skin pain and psoriasis
- Laurent Misery, Jason Shourick, Charles Taieb
- Evaluation of adalimumab biosimilar in treatment of psoriatic arthritis with concomitant moderate to severe chronic plaque psoriasis: An open-labeled, prospective, pilot case series
- Sujay Khandpur, Prateek Sondhi, Neha Taneja, Preeti Sharma, Dayasagar Das, Alpana Sharma, Vishnubatla Sreenivas
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?